Stock Events

Biomarin Pharmaceutical (BMRN) Q2 2024 Earnings

BMRN -1.22%
24AprConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0.2
0.3
0.39
0.49

Details

Expected EPS
0.311832
Actual EPS
0.46
Surprise EPS
0.15
Surprise Percent
+47.52%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 0.46 per share for Q2 2024.

0 Comments

Share your thoughts